Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes

NCT00736879 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

497

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Dapagliflozin
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]